Pmv Pharmaceuticals, Inc. · NASDAQ:PMVP

Orbimed Advisors LLC reported a 9.40% stake in Pmv Pharmaceuticals, Inc. (Schedule 13D/A)

Event Oct 23, 2025 · Filed Oct 27, 2025

Orbimed Advisors LLC reported a 9.40% stake in Pmv Pharmaceuticals, Inc., 4,975,291 shares, with active intent on Oct 23, 2025. Filed Oct 27, 2025 (Schedule 13D/A).

Stake
9.40%
Shares
4,975,291
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC9.40%4,975,291
ORBIMED CAPITAL GP V LLC9.40%4,975,291

Source

View original at SEC

Related